BNTX to Present ASCO Data for Pumitamig, Gotistobart, Highlighting 25+ Phase 2/3 Trials, 13 Pivotal Studies Across Late-Stage Oncology Pipeline
BioNTech SE American Depositary Share · Now $95.95
+1.4% in 3d after detection
Post-detection moves
1h
+0.0%
1d
-1.0%
3d
+1.4%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS